These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8801029)
21. Angiotensin converting enzyme inhibition therapy following myocardial infarction. Rationale for clinical trials. Pfeffer MA Herz; 1991 Sep; 16 Spec No 1():278-82. PubMed ID: 1840297 [TBL] [Abstract][Full Text] [Related]
22. ACE inhibitors for congestive heart failure. Med Lett Drugs Ther; 1988 Oct; 30(777):97-8. PubMed ID: 3173235 [No Abstract] [Full Text] [Related]
23. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors. Sigurdsson A Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749 [TBL] [Abstract][Full Text] [Related]
24. [ACE inhibitor or ATII receptor blocker in heart failure and myocardial infarction?]. Landmark K; Reikvam A Tidsskr Nor Laegeforen; 2005 Jan; 125(1):38-40. PubMed ID: 15643463 [TBL] [Abstract][Full Text] [Related]
25. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction? McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527 [No Abstract] [Full Text] [Related]
26. Update of recent clinical trials in heart failure and myocardial infarction. Richardson M; Cockburn N; Cleland JG Eur J Heart Fail; 1999 Mar; 1(1):109-15. PubMed ID: 10937988 [TBL] [Abstract][Full Text] [Related]
27. What is the role of angiotensin-converting enzyme inhibitors in congestive heart failure and after myocardial infarction? Nelson KM; Yeager BF Ann Pharmacother; 1996 Sep; 30(9):986-93. PubMed ID: 8876861 [TBL] [Abstract][Full Text] [Related]
28. ACE inhibitors vs. angiotensin II receptor blockers in acute myocardial infarction and heart failure. Gold JA; Rahko PS WMJ; 2004; 103(1):71-2. PubMed ID: 15101473 [No Abstract] [Full Text] [Related]
29. [Value in heart failure proven again. AT II blocker soon also for post-infarct patients?]. MMW Fortschr Med; 2003 Oct; 145(43):51. PubMed ID: 14664222 [No Abstract] [Full Text] [Related]
30. [The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases]. Ferrari R; Ambrosio G; Chiariello M Ital Heart J; 2005 Nov; 6 Suppl 7():3S-4S. PubMed ID: 16485511 [No Abstract] [Full Text] [Related]
31. Angiotensin converting enzyme inhibitors for hypertension and heart failure? Cleland JG Postgrad Med J; 1992 Jan; 68(795):1-5. PubMed ID: 1561182 [No Abstract] [Full Text] [Related]
32. ACE inhibitor therapy: benefits and underuse. Smith SC Am Fam Physician; 1999 Jan; 59(1):35-6, 38. PubMed ID: 9917572 [No Abstract] [Full Text] [Related]
33. ACE inhibitors after myocardial infarction. Poole-Wilson PA Lancet; 1994 Jan; 343(8892):289-90. PubMed ID: 7905109 [No Abstract] [Full Text] [Related]
34. Angiotensin-converting enzyme inhibitors in hypertension and congestive heart failure. Gavras I; Gavras H Adv Intern Med; 1990; 35():249-67. PubMed ID: 2405595 [No Abstract] [Full Text] [Related]
35. [Angiotensin-converting enzyme inhibitors in the treatment of heart failure: toward a change in the natural history of the disease]. Martín Luengo C; Arribas Jiménez A; Nieto Ballestero F; Diego Domínguez M; Cascón Bueno M; Pabón Osuna P; Sala Sánchez-Castillo A Rev Esp Cardiol; 1993 Mar; 46(3):131-45. PubMed ID: 8488316 [No Abstract] [Full Text] [Related]
36. Prevention of remodeling of the heart after myocardial infarction. Gorlin R Mt Sinai J Med; 1995 Sep; 62(4):287-92. PubMed ID: 7565851 [TBL] [Abstract][Full Text] [Related]